Magnetic resonance imaging‐quantified small bowel motility is a sensitive marker of response to medical therapy in Crohn's disease
Alimentary Pharmacology & Therapeutics2015Vol. 42(3), pp. 343–355
Citations Over TimeTop 10% of 2015 papers
Andrew Plumb, Alex Menys, E Russo, Davide Prezzi, Gauraang Bhatnagar, Roser Vega, Steve Halligan, T. Orchard, Stuart A. Taylor
Abstract
Improved MRI-measured small bowel motility accurately detects response to anti-TNFα therapy for Crohn's disease, even as early as 12 weeks. Motility MRI may permit early identification of nonresponse to anti-TNFα agents, allowing personalised treatment.
Related Papers
- → Evidence That Focal Adhesion Complexes Power Bacterial Gliding Motility(2007)247 cited
- → Defining motility in the Staphylococci(2017)95 cited
- → Effects of carnitine and some related compounds on the motility of rat spermatozoa from the caput epididymidis(1981)66 cited
- → Patterns of motility in human leukemias: A study by time-lapse cinematography(1978)10 cited